These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22846867)

  • 1. Chemoembolization for hepatocellular carcinoma.
    Lencioni R
    Semin Oncol; 2012 Aug; 39(4):503-9. PubMed ID: 22846867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization in patients with hepatocellular carcinoma.
    Lencioni R
    Liver Cancer; 2012 Jun; 1(1):41-50. PubMed ID: 24159570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design.
    Burrel M; Reig M; Forner A; Barrufet M; de Lope CR; Tremosini S; Ayuso C; Llovet JM; Real MI; Bruix J
    J Hepatol; 2012 Jun; 56(6):1330-5. PubMed ID: 22314428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loco-regional treatment of hepatocellular carcinoma.
    Lencioni R
    Hepatology; 2010 Aug; 52(2):762-73. PubMed ID: 20564355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective.
    Takayasu K
    Oncology; 2011; 81 Suppl 1():105-10. PubMed ID: 22212943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R; Kooby DA; Staley CA; Kauh JS; Khanna V; Kim HS
    J Surg Oncol; 2010 May; 101(6):476-80. PubMed ID: 20213741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoembolization of hepatocellular carcinoma--what to tell the skeptics: review and meta-analysis.
    Ramsey DE; Geschwind JF
    Tech Vasc Interv Radiol; 2002 Sep; 5(3):122-6. PubMed ID: 12524642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival benefit with intraarterial techniques in hepatocellular carcinoma].
    Sangro B
    Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():95-101. PubMed ID: 25087719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
    Raoul JL; Sangro B; Forner A; Mazzaferro V; Piscaglia F; Bolondi L; Lencioni R
    Cancer Treat Rev; 2011 May; 37(3):212-20. PubMed ID: 20724077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoembolization of hepatocellular carcinoma.
    Lencioni R; Petruzzi P; Crocetti L
    Semin Intervent Radiol; 2013 Mar; 30(1):3-11. PubMed ID: 24436512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma.
    Arabi M; BenMousa A; Bzeizi K; Garad F; Ahmed I; Al-Otaibi M
    Saudi J Gastroenterol; 2015; 21(3):175-80. PubMed ID: 26021777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: recent progression and perspective.
    Takayasu K
    Oncology; 2013; 84 Suppl 1():28-33. PubMed ID: 23428855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects.
    Lencioni R; Crocetti L; De Simone P; Filipponi F
    Transpl Int; 2010 Jul; 23(7):698-703. PubMed ID: 20492618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Huang K; Zhou Q; Wang R; Cheng D; Ma Y
    J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma.
    van Malenstein H; Maleux G; Vandecaveye V; Heye S; Laleman W; van Pelt J; Vaninbroukx J; Nevens F; Verslype C
    Onkologie; 2011; 34(7):368-76. PubMed ID: 21734423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in transarterial chemoembolization of hepatocellular carcinoma.
    Huppert P
    Abdom Imaging; 2011 Dec; 36(6):677-83. PubMed ID: 21674193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.